With a revenue increase of 33.61% in the second quarter 2026, year on year to cumulative value of $941 million, Biocryst Pharmaceuticals Inc 's revenue per employee grew on a trailing twelve months basis to $ 2,162,329, this marks a new company high.
Within the Healthcare sector Employees of 31 other companies have achieved higher revenue per employee. While revenue/employee total ranking has improved so far to 423, from total ranking in previous quarter at 564. Biocryst Pharmaceuticals Inc has 435 employees.

What is Sales per Employee Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Revenue per Employee▼

None ▼

Revenue per Employee▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

BCRX Revenue per Employee	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Revenue Change	33.61 %	7.48 %	209.09 %	36.14 %	49.41 %
Sales per Employee (TTM) $	2,162,329	2,036,129	2,011,120	1,378,887	1,281,623
BCRX's Total Ranking	# 423	# 564	# 641	# 680	# 769
Seq. Revenue Change	39.53 %	-61.53 %	155.06 %	-2.42 %	12.24 %

BCRX Company Profile >> Back to BCRX Efficiency Comparisons >> Compare BCRX Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within:	No.
Biotechnology & Pharmaceuticals Industry	# 5
Healthcare Sector	# 32
Overall Market	# 423

Revenue per Employee Statistics
High	Average	Low
$ 2,162,329	$ 380,929	$ 24,977
(Jun 30 2026)		(Sep 30 2013)

Financial Statements
Biocryst Pharmaceuticals Inc 's Revenue MRQ	$ 218 Millions	Visit BCRX's Income Statement
Biocryst Pharmaceuticals Inc 's Revenues TTM	$ 941 Millions	Visit BCRX's aggregate revenue growth
What are BCRX's Sales?		Visit BCRX's Sales by Segment

Other Ratios
Biocryst Pharmaceuticals Inc 's Income per Employee
Employees in Biotechnology & Pharmaceuticals
Biotechnology & Pharmaceuticals Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
BCRX's Revenue per Employee versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for BCRX's Competitors
Revenue per Employee for BCRX's Suppliers
Revenue per Employee for BCRX's Customers

You may also want to know
BCRX's Sales Growth Rates	BCRX's Pe Price to earnings ratio	BCRX's Receivables Turnover Ratio	BCRX's Stock Quote
BCRX's Net Income Growth Rates	BCRX's Ps Price to Sales ratio	BCRX's Sales per Employee	BCRX's Asset Turnover Ratio
BCRX's Net Margin	BCRX's Pb Price to Book ratio	BCRX's Financial Strength Ratios	BCRX's Dividend Payout Ratio

Date modified: 2026-09-09T22:24:46+00:00

Companies with similar Revenue per Employee for 12 months ending Jun 30 2026, within Healthcare Sector	Revenue per Employee	Revenue 12 months ending Jun 30 2026	Number of Employees Jun 30 2026
Vaxart Inc	3,739,446.15	$ 243.064 Million	65
Illumina Inc	3,510,156.25	$ 4,493.000 Million	1,280
Harmony Biosciences Holdings inc	3,277,102.39	$ 960.191 Million	293
Therapeuticsmd Inc	3,270,000.00	$ 3.270 Million	1
Aurinia Pharmaceuticals Inc	2,433,648.44	$ 311.507 Million	128
Eton Pharmaceuticals Inc	2,392,704.55	$ 105.279 Million	44
Cormedix Inc	2,366,196.28	$ 451.943 Million	191
Biocryst Pharmaceuticals Inc	2,162,328.74	$ 940.613 Million	435
Elite Pharmaceuticals Inc	2,155,839.86	$ 140.130 Million	65
Zevra Therapeutics Inc	2,112,377.05	$ 128.855 Million	61
Liquidia Corporation	2,087,532.41	$ 450.907 Million	216
Tg Therapeutics Inc	2,003,849.62	$ 799.536 Million	399
Prestige Consumer Healthcare Inc	1,938,521.05	$ 1,104.957 Million	570
Privia Health Group Inc	1,923,384.18	$ 2,358.069 Million	1,226
Gilead Sciences Inc	1,791,588.24	$ 30,457.000 Million	17,000
Collegium Pharmaceutical Inc	1,777,172.58	$ 751.744 Million	423
Fennec Pharmaceuticals Inc	1,692,028.57	$ 59.221 Million	35
Neurocrine Biosciences Inc	1,686,950.00	$ 3,373.900 Million	2,000
Mirum Pharmaceuticals Inc	1,661,470.43	$ 618.067 Million	372
Tarsus Pharmaceuticals Inc	1,638,732.43	$ 606.331 Million	370
Agenus Inc	1,638,185.19	$ 132.693 Million	81
Xenetic Biosciences Inc	1,630,388.50	$ 3.261 Million	2
Ideaya Biosciences Inc	1,614,668.97	$ 234.127 Million	145
Rigel Pharmaceuticals Inc	1,590,718.39	$ 276.785 Million	174
Progyny Inc	1,531,890.19	$ 1,311.298 Million	856
Acadia Pharmaceuticals Inc	1,426,870.93	$ 1,138.643 Million	798
Arcutis Biotherapeutics Inc	1,310,680.79	$ 463.981 Million	354
Lantheus Holdings Inc	1,303,724.22	$ 1,555.343 Million	1,193
Cue Biopharma Inc	1,298,413.79	$ 37.654 Million	29
Puma Biotechnology Inc	1,291,865.92	$ 231.244 Million	179

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.